ON DEMAND - LAAO SUMMIT 2026
Left Atrial Appendage Occlusion continues to advance as a key strategy for stroke prevention in patients with atrial fibrillation. This year’s summit brought together LAAO experts to share best practices across the patient journey, focusing on imaging, technique and device iteration, post‑implant management and outcomes, evolving indications, and the convergence of rhythm and structural therapies.
SESSION 1: IMAGING, TECHNIQUE & DEVICE ITERATION
Defining the Present and Forecasting the Future O. de Backer
Advancing LAAO to Minimize Peri-Device Leaks M. Bergmann
Preventing Device‑Related Thrombus in LAAO P. Garot & I. Cruz
Imaging Essentials N. Wunderlich
Technology Spotlight: Amulet 360 in Action X. Freixa & L. Sanchis
SESSION 2: POST-IMPLANT MANAGEMENT & LONGTERM OUTCOMES
Patient-Tailored Therapy & Cognitive Risk U. Schulz
Device-Related Thrombosis (DRT) J.E. Nielsen-Kudsk
Clinical Strategies managing DRT P. Salinas
Drug-Coated Devices: Can they reduce DRT? R. Ibrahim
SESSION 3: CLINICAL EVIDENCE & EVOLVING INDICATIONS
Latest Evidence in LAAO I. Eitel
Trials Influencing Indication Expansion G. Fassini
OPTION Trial T. Lewalter
SESSION 4: CROSSROADS OF RHYTHM & STRUCTURE
PFA Meets LAAO L. Boldt
Strategic Planning for Concomitant Procedures A. Lepillier
Case Review D. Nair
LAAO Summit Closing Session